Abstract: Methods and systems for determining water status in plant tissue are provided. A number of systems are capable of using terahertz signals to generate signals measuring total water content in plant tissue, including plant leaves. Using these signals, methods are capable of determining water status variables, including water mass per leaf area, relative water content, and leaf water potential, which can aid in agricultural, ecological, and environmental health, such as dehydration and droughst stress of plants.

Abstract: Provided herein are a pipeline inspection system for effectively managing a pipeline by inspecting a state of the pipeline while moving along the pipeline. Moreover, the pipeline inspection system and the maintenance method using the same can improve scale removal efficiency by removing scale accumulated on the inner wall of the pipeline with ultrasonic vibrations, and prevent water leakage due to the corrosion of the inner wall of the pipeline.

Abstract: A system of image processing based emotion recognition is disclosed. The system principally comprises a camera and a main processor. Particularly, there a plurality of function units provided in the main processor, including: face detection unit, feature processing module, feature combination unit, conversion module, facial action judging unit, and emotion recognition unit. According to the present invention, the emotion recognition unit is configured to utilize a facial emotion recognition (FER) model to evaluate or distinguish an emotion state of a user based on at least one facial action, at least one emotional dimension, and a plurality of emotional scores. As a result, the accuracy of the emotion recognition conducted by the emotion recognition unit is significantly enhanced because basis of the emotion recognition comprises basic emotions, emotional dimension(s) and the user's facial action.

Abstract: Highly concentrated solutions are disclosed along with methods of inhibiting and/or ameliorating functional neurological disorders of the brain. The method may include administering directly to a brain of a subject a medicament multiple times over a time period of at least two days. The medicament may include a half-life of less than 2 hour in the cerebrospinal fluid. The method may include inhibiting and/or ameliorating a functional neurological disorder of the brain using the medicant.

Abstract: A patient care system may collect and analyze data regarding characteristics of an individual to identify any health, medical, and/or physiological conditions associated with the individual. Trend analysis may predict an onset of a medical condition associated with the individual. Trend analysis may determine and/or identify one or more target areas (e.g., geographical areas) where individuals experience particular symptoms and/or affected by various health, medical, and/or mental issues. An alert, diagnosis, and/or treatment plan may be determined for an individual based on a corpus of information collected from and/or associated with multiple individuals.

Abstract: Described herein are reusable, mesh-based catalysts with superior mechanical stability and magnetic separability wherein the mesh may be formed in a variety of shapes and can be easily separated from a process stream and in combination with biomass torrefaction, reduces toxic emissions and produce hydrogen gas, which can be burned at the facility to generate heat or electricity.

Abstract: Compositions, systems and methods for delivering CRISPR/Cas9-based genome editing system and a donor protein to a cell.

Abstract: Proposed is a phase shift introduction method, a structure, and a circuit device for eliminating or minimizing a risk associated with dissimilar materials, solving in principle a problem of mixing of a signal current and a control current that occurs due to DC connection of a phase shifter to a signal line, and stably and reliably providing a phase shift that is desired to be introduced without being adversely effected by noise generated by an ambient magnetic field, which is generated due to use of an external power supply. A structure according to the present invention includes a phase shifter 101 and a closed-loop circuit 103 that is directly used for computation or storage, and a quantum phase shift is generated in the closed-loop circuit 103 by using a fractional flux quantum captured by the phase shifter 101 that is DC-separated from the closed-loop circuit 103.

Abstract: Provided is a method of transferring a material into cells, comprising the steps of: forming droplets consisting of a material to be transferred and cells; and a step of subjecting the formed droplets to deformation, thereby transferring the material to be transferred, into the cells.

Abstract: Provided are compositions that can be employed for generating microporous gel systems. In some embodiments, the compositions include at least one sub-population of soft hydrogel microparticles with a Youngs modulus of less than 50 kPa and at least one sub-population of stiff hydrogel microparticles with a Young's modulus of greater than 90 kPa. Also provided are methods for generating the compositions, methods for treating bone and/or cartilage defects in subject using the disclosed compositions, methods for treating osteoarthritis using the disclosed compositions, and methods for providing orthopedic implants to subjects.

Abstract: Methods and systems for low-power wireless sensor networks of conductivity probes for the detection of corrosive fluids inside pressure vessels and piping are described. Conductivity probes that can be easily integrated into existing internal corrosion monitoring infrastructure (access fittings) and connected via a low-power wireless sensor network are described herein.

Abstract: Aspects of the subject disclosure may include, a non-linear energy detector that obtains baseband information from a mixed signal that corresponds to an information component of a received radio frequency (RF) signal, wherein the mixed signal comprises a local oscillator signal combined, without multiplication, with the received RF signal, wherein the received RF signal comprises a carrier wave component operating at a carrier frequency within a millimeter wave spectrum, wherein the non-linear energy detector is associated with a non-linear current-voltage (I-V) characteristic curve, and wherein the baseband information is obtained by applying the mixed signal to the non-linear I-V characteristic curve. Other embodiments are disclosed.

Abstract: The present disclosure provides a method that embodies a simple and effective route to remove homogeneous catalysts from solutions wherein NMR/MRI signal amplification by reversible exchange (SABRE) or parahydrogen-induced polarization (PHIP) is performed. A method for recovering a homogeneous SABRE/PHIP catalyst for reuse is also described.

Abstract: Provided are composite electrolytes having a bio-based gel electrolyte in an ordered structure of a porous solid. In some embodiments, the gel electrolyte includes a glycolate gel, a glycerate gel, a bio-based compound-derived gel or a combination thereof. Also provided are electrochemical systems (electrodeposition), redox flow batteries, fuel cells, lithium-ion batteries and lithium-metal batteries including the composite electrolytes, and methods for producing gel electrolytes. In some embodiments, the methods including reacting a polyol, optionally ethylene glycol, propanediol, butanediol, pentanediol, diethylene glycol, glycerol, or any combination thereof, with a lithium metal and/or a lithium salt, optionally lithium hydroxide, a sodium salt, optionally sodium hydroxide (NaOH), NaTFSI, NaBF4, or NaPF6; an aluminum salt; a potassium salt, a magnesium salt; a calcium salt; a zinc salt; or any combination thereof.

Abstract: Provided herein are methods for preventing or treating a psychological disorder. A serotonin agonist or an agonist of serotonin receptors is administered separately, sequentially or simultaneously in combination with a serotonin receptor 2A antagonist.

Abstract: The disclosure describes imaging and therapy techniques comprising nanodroplets. More particularly, aspects of the disclosure relate to the use of nanodroplets to modify nanobubbles or microbubbles to provide improved imaging and/or therapeutic techniques and compositions.

Abstract: Systems and methods for a multi-primary color system for display. A multi-primary color system increases the number of primary colors available in a color system and color system equipment. Increasing the number of primary colors reduces metameric errors from viewer to viewer. One embodiment of the multi-primary color system includes Red, Green, Blue, Cyan, Yellow, and Magenta primaries. The systems of the present invention maintain compatibility with existing color systems and equipment and provide systems for backwards compatibility with older color systems.

Abstract: A compound, Ir(LA)m(LB)3-m, having a structure of Formula I, is provided. In Formula I, each of moiety A and moiety C is independently a 5- or 6-membered ring or a polycyclic fused ring system comprising 5- or 6-membered rings; moiety B is a 5-membered heterocyclic ring; Z1, Z2, and Z3 are C or N; m is 1 or 2; at least one of R1, R2, R3, R4 has a structure of Formula II, or is a 5-membered heterocyclic ring; each of X1, X2, X3, X4, and X5 is CR or N; each of R1, R2, R3, R4, RA, RB, RC, and R is hydrogen or a General Substituent; at least one of R1a, R2a, R3a, R4a, R5a is cycloalkyl, alkyl, silyl, germyl, deuterated variants thereof, fluorinated variants thereof, and combinations thereof. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: Provided herein are methods and a device for collecting biological samples. In particular, the present disclosure relates to a device designed to specifically capture samples within the target areas of a patient for specific cell collection for particular diagnosis.

Abstract: An embodiment in accordance with the present invention provides a device and method for the treatment of urethral stricture. The present invention places and holds a graft at an incised urethral stricture site for 5-21 days, while the graft adherences to the incised urethral stricture site. A device of the present invention includes a delivery component, a graft carrier component, and a removal component. In some embodiments, the delivery and removal components may be combined into the same device. The delivery component, the graft carrier component, and the removal component are all configured to enter and exit the urethra without trauma. A method according to an embodiment of the present invention includes harvesting a graft, loading the graft onto the graft carrier component, introducing the delivery device into the urethra with the graft carrier component and graft loaded, and delivering of the graft to the incised urethral stricture site.